What did Integra LifeSciences Holdings Corp. pay for Acclarent, Inc.?

Integra LifeSciences Holdings Corp. acquired Acclarent, Inc. for $275.0M in 2023, equivalent to 2.50x revenue. Target revenue was approximately $110.0M.

What does Acclarent, Inc. do?

Acclarent, Inc. is a medical devices business.

What multiple did Integra LifeSciences Holdings Corp. pay for Acclarent, Inc.?

2.50x revenue, based on disclosed deal value of $275.0M and disclosed financials.

M&A TRANSACTION · 2023

Acclarent, Inc. acquired by Integra LifeSciences Holdings Corp.

$275.0M· 2.50x revenue

Target

Acclarent, Inc.

Acquirer

Integra LifeSciences Holdings Corp.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$110.0M

EBITDA

—

Deal Value

$275.0M

EV/EBITDA

—

Context

This $275.0M acquisition of Acclarent, Inc. by Integra LifeSciences Holdings Corp. sits in the medical devices sub-vertical. Integra LifeSciences Holdings Corp. is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Acclarent, Inc. acquisition.

Citation: ExitValue.ai. (2023). Acclarent, Inc. acquired by Integra LifeSciences Holdings Corp.. https://exitvalue.ai/deals/acclarent-inc-acquired-by-integra-lifesciences-holdings-corp-hc-2023-0036